BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1447982)

  • 1. Calcitriol and postmenopausal osteoporosis.
    Sambrook P
    Med J Aust; 1992 Sep; 157(6):364-6. PubMed ID: 1447982
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis after 60.
    Smith R
    BMJ; 1990 Sep; 301(6750):452-3. PubMed ID: 2119835
    [No Abstract]   [Full Text] [Related]  

  • 3. Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?
    Deal C
    Cleve Clin J Med; 2000 Oct; 67(10):696-8. PubMed ID: 11060955
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of osteoporosis: current and future.
    Stone MD; Hosking DJ
    Ann Rheum Dis; 1991 Oct; 50(10):663-5. PubMed ID: 1958084
    [No Abstract]   [Full Text] [Related]  

  • 5. New treatments for osteoporosis.
    Lancet; 1990 May; 335(8697):1065-6. PubMed ID: 1970372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Osteoporosis: its diagnosis, its consequences].
    Hardouin P
    Rev Stomatol Chir Maxillofac; 1997 Nov; 98 Suppl 1():93-5. PubMed ID: 9471709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a modified etidronate cyclical regimen on postmenopausal osteoporosis: a four-year study.
    Lyritis GP; Tsakalakos N; Paspati I; Skarantavos G; Galanos A; Androulakis C
    Clin Rheumatol; 1997 Jun; 16(4):354-60. PubMed ID: 9259248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect on bone density in male osteoporosis of postmenopausal osteoporosis treatment (fluoride, etidronate, and calcitriol).
    Laroche M; Andrieu V; Constantin A; Mazières B
    Clin Exp Rheumatol; 1998; 16(6):760. PubMed ID: 9844778
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women.
    Miller PD; Neal BJ; McIntyre DO; Yanover MJ; Anger MS; Kowalski L
    Osteoporos Int; 1991 Jun; 1(3):171-6. PubMed ID: 1790405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis: trials and tribulations.
    Seeman E
    Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention and treatment of osteoporosis.
    Golden BD
    Arthritis Care Res; 1998 Apr; 11(2):124-34. PubMed ID: 9668735
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
    Gürlek A; Bayraktar M; Gedik O
    Calcif Tissue Int; 1997 Jul; 61(1):39-43. PubMed ID: 9192511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogens, anabolic steroids and postmenopausal osteoporosis: what are the facts?].
    Birkenhäger JC
    Ned Tijdschr Geneeskd; 1991 Jun; 135(22):973-5. PubMed ID: 2062392
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing osteoporosis-related fractures: an overview.
    Gass M; Dawson-Hughes B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
    Need AG; Morris HA; Horowitz M; Nordin BE
    Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
    Compston JE
    Bone; 2000 Dec; 27(6):765-8. PubMed ID: 11113386
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of a combined alendronate and calcitriol agent (Maxmarvil®) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study.
    Rhee Y; Song K; Park S; Park HS; Lim SK; Park BW
    Endocr J; 2013; 60(2):167-72. PubMed ID: 23064476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
    Reginster JY
    Clin Exp Rheumatol; 2001; 19(2):121-2. PubMed ID: 11326471
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatments for osteoporosis in postmenopausal women.
    Brockie J
    Community Nurse; 1999 Jul; 5(6):32-3. PubMed ID: 10524029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and treatment of osteoporosis].
    Galus K
    Pol Arch Med Wewn; 2005 Dec; 114(6):1236-43. PubMed ID: 16789495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.